Our team – how lucky we are! – just attended the 2015 Texas FreshAIR biotech conference, where we heard from Google Life Sciences CEO Dr. Andy Conrad on all things Google, including the company’s effort to improve healthcare through new sensors and better data analytics.
Do you ever wonder what gets a scientist’s blood pumping? What about diabetes research excites her? What makes her want to work harder to find that cure? Look no further! As a researcher working toward a cure for diabetes, I present you with my top 5 list.
In exciting news, the personal genetics company 23andMe announced today the launch of its new “Personal Genome Service,” which has now received formal FDA approval.
A new study finds that people with diabetes in the U.S. are paying between 5.7 times and 7.5 times more than those in the UK for two popular insulins and a rare drug to treat diabetic retinopathy. U.S. consumers absorb this higher cost despite often not being the first in line to have access to […]
In a move sure to befuddle women — and anger some breast cancer survivors — the American Cancer Society has issued new guidelines saying less screening for breast cancer is better than more.
High blood sugar and increased body weight due to a high-fat diet could lead to symptoms of depression and anxiety, according to new research.
Mike tells a story about how your smartphone and CGM can save you from dangerous hypoglycemia.
Diabetic macular edema (DME) is a leading source of vision loss around the world, affecting about a fifth of people with long-term diabetes. Drugs that target a protein known as VEGF (vascular endothelial growth factor) inside the eye have greatly improved the treatment options in recent years, but only about half of DME patients are […]
Recent research reinforces the notion that metformin may have other benefits, such as helping to prevent certain cancers.
There is no right or wrong way to manage your diabetes. With that being said, there are a variety of options and devices that can be used for proper diabetes management.
The study measures customer satisfaction with blood glucose meters based on six factors (in order of importance): performance (26%); ease of use (24%); design (20%); features (19%); cost of test strips (6%); and training (5%). Satisfaction is calculated on a 1,000-point scale. Overall satisfaction with blood glucose meters has increased to 826 this year, up […]
Researchers were precise when they designed the study, including only men and women between the ages of 40 and 75 with stable, type 2 diabetes — they couldn’t need more than two insulin injections a day or be on an insulin pump. People were also excluded if they smoked or had a history of heart […]
The best type of weight-loss surgery for diabetes control is gastric bypass, according to new research published in JAMA Surgery.
In a study published in Cell, Host & Microbe earlier this year, the largest longitudinal study of the microbiome to date, researchers saw dramatic shifts in the gut bacteria of children who went on to develop type 1 diabetes. The study could have important implications for identifying the disease at a very early stage, delaying […]
When it comes to diabetes, the correct response to the above cliché is, “No kidding.” There’s no shortage of apps these days claiming to make life easier for PWDs (people with diabetes). Add two more to that ever-growing list.
Studies have shown that both bariatric surgery and extreme low-calorie diets can reverse more established Type 2 diabetes, but “we still need more information on how long the remission is going to last,” Dr. Fradkin said.
Researchers in the UK found that an experimental closed-loop artificial pancreas system did better than humans alone at managing Type 1 diabetes, according to a Reuters report. The closed-loop software, which could be turned on and off at will, included a glucose sensor and insulin pump that sent wireless signals every 12 minutes to adjust […]
As always, there’s been no shortage of outstanding diabetes blog posts falling from the proverbial tree that is the Diabetes Online Community (DOC). Today, we’re excited to share some that caught our eye during September, along with some posts recommended by DOC peep readers.
On September 25, 2015, the FDA has approved Tresiba (insulin degludec SC injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart SC injection) as one of the treatment options to improve glycemic controls in adults with diabetes mellitus.
The Oxford University study provides the strongest evidence yet of a link between the two conditions. Experts behind the study said more research was needed to see whether using drugs to lower blood pressure would help prevent people developing type 2 diabetes.